Patents Assigned to Merck Serona SA
  • Humanized antibodies against human IL-22RA
    Patent number: 8545844
    Abstract: The invention relates to humanized antibodies against human IL-22RA and to their use in the treatment of psoriasis and other immune-mediated diseases such as psoriatic arthritis and atopic dermatitis.
    Type: Grant
    Filed: November 12, 2010
    Date of Patent: October 1, 2013
    Assignee: Merck Serona SA
    Inventors: Roland Beckmann, Caroline Johnson-Leger